The expression was also correlated with the ER, PR, and HER2 status, as well as the LDH levels(all P less than 0.05), whereas patients’ age, clinical stage, and lymph node metastasis had no effect on the levels. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.